Guardian Pharmacy Services, Inc. (GRDN) on Decifer

Decifer ranks GRDN number 133 of 273 tracked names on durable business quality.

Why it ranks here

• It earns strong returns on the money it puts to work, around 23% and it turns most of its profit into real cash.
• Revenue is growing about 18% a year, profits grew 145% over the past year, and growth is speeding up, not slowing down.
• It keeps a thin share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• And it returns cash to shareholders.
• Returns near 23% and profits up 145% show health but lack of a worldview role and momentum of 13 out of 35 cap the investability.

The current read

The evidence on GRDN lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Care Delivery & Ageing Services: The population needing daily care is growing faster than the clinical workforce serving it, and payers are moving that care to the cheapest adequate setting, which shifts volume from hospitals to home and post-acute operators.

Read the full GRDN research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.